NIH Unveils New Opioid Research Plans

(MedPage Today) -- HEAL initiative seeks to combat addiction, improve pain management
Source: MedPage Today Neurology - Category: Neurology Source Type: news

Related Links:

People who work in manual labor have higher rates of injury and overdose Our country’s ongoing opioid crisis has many faces, from teenagers on Cape Cod to middle-aged parents in West Virginia. A recent report from the Massachusetts Department of Public Health provides another demographic affected by opioids: people who work in the trade industries, namely construction. The report broke down overdose deaths by industry, and construction workers were involved in almost a quarter of overdose deaths recorded in the state over five years. Farming, forestry, and hunting, along with fishing, are the next most dangerous indu...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Addiction Source Type: blogs
We  learned last week that the 2017 drug overdose numbers reported by the US Centers for Disease Control and Prevention clearly show most opioid-related deaths are due to illicit fentanyl and heroin, while deaths due to prescription opioids have stabilized, continuing a steady trend for the past several years. I’ve encouraged using the term “Fentanyl Crisis” rather than “Opioid Crisis” to describe the situation, because it more accurately points to its cause—nonmedical users accessing drugs in the dangerous black market fueled by drug prohibition—hoping thi...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
As part of a wide-ranging deal between President Donald Trump and Chinese leader Xi Jinping, China has reportedly pledged to designate the potent synthetic opioid fentanyl and similar drugs as controlled substances, subjecting those who sell them to harsher punishments and potentially slowing their flow into the U.S. Last month, a Congressional commission said China — which it previously called the “largest source of illicit fentanyl and fentanyl-like substances in the United States” — was not doing enough to stop the drug and its related analogs from reaching U.S. borders. The Trump Administration ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized China healthytime onetime public health Source Type: news
(Image from Unsplash.com) The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to produce devices intended to predict the risk of opioid used disorder (OUD), detect opioid overdose, dispense medication and provide pain treatment alternatives to opioids. (Source: FDA) The selected firms will work c...
Source: Mass Device - Category: Medical Devices Authors: Tags: Blog Food & Drug Administration (FDA) Implants Pain Management Research & Development algometRx Avanos Medical (formerly Halyard Health) Brainsway cognifisense ipill Masimo milliman ThermoTek Source Type: news
Implantable technologies have come a long way over the years, and advancements in micro and nanotechnologies have helped device developers continue to push the envelope even further. Within the realm of drug delivery, advances in nanotechnologies have consistently improved patient outcomes by enabling sustained drug delivery to help treat chronic conditions. These scalable technologies have even offered localized drug delivery that can further improve bioavailability. While many of these technologies offer a variety of opportunities, we’re still eagerly awaiting to see the impact of these advancements onc...
Source: MDDI - Category: Medical Devices Authors: Tags: BIOMEDevice San Jose Implants Source Type: news
CONCLUSIONS: The current understanding of the risks and benefits of continuing or stopping buprenorphine perioperatively is limited by a lack of high-quality evidence. Observational studies and case reports indicate no evidence against continuing buprenorphine perioperatively, especially when the dose is
Source: Canadian Journal of Anaesthesia - Category: Anesthesiology Authors: Tags: Can J Anaesth Source Type: research
ConclusionsThe current understanding of the risks and benefits of continuing or stopping buprenorphine perioperatively is limited by a lack of high-quality evidence. Observational studies and case reports indicate no evidence against continuing buprenorphine perioperatively, especially when the dose is
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
In the midst of a fast-paced, 21st-century life, it's possible for a hard-working nurse to experience what I call Nursing Career Attention Deficit Disorder (NCADD). In this context, the nurse in question loses sight of her goals and dreams, instead becoming scattered and distracted by life's myriad responsibilities and demands; she's pulled in multiple directions and feels like she's running around like a chicken with her head cut off. Can NCADD be turned around? Can our distracted minds be tamed in the interest of developing a more satisfying nursing career?Photo by chuttersnap on UnsplashAn Understandable ...
Source: Digital Doorway - Category: Nursing Tags: career career development career management careers healthcare careers nurse nurse careers nurses nursing nursing careers Source Type: blogs
Vertiflex yesterday released results from a trial of its Superion indirect decompression system in patients with lumbar spinal stenosis, touting a significant reduction in the number of patients using opioids to manage pain at five years post-treatment. Results from the trial were published in the Journal of Pain Research, the company said. “These findings demonstrate that treatment with IPD, a minimally-invasive treatment option for LSS, can provide effective pain relief while markedly decreasing the need for prescription opioid medications,” lead author Dr. Pierce Nunley of the Spine Institute of Louisiana sa...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Pain Management Spinal VertiFlex Inc. Source Type: news
This study was performed by the MPN Quality of Life Study Group. A survey was designed by a team of MPN investigators experienced with MPN symptomatology. Patients completed the MPN-10, a 10 item survey of MPN symptoms completed on a 0 (absent) to 10 (worst imaginable) scale (Blood. 2011 Jul 14;118(2):401-8). Other surveyed tools included the Opioid Risk Tool (ORT) as well as DSMV criteria for Opioid Use Disorder (OUD). The survey was posted on high-traffic MPN-related webpages focused on patient education and advocacy (MPN Forum, MPN Net, MPN Research Foundation, MPN Voice)for a total of 28 days. Patients currently receiv...
Source: Blood - Category: Hematology Authors: Tags: 634. Myeloproliferative Syndromes: Clinical: Poster III Source Type: research
More News: Addiction | Brain | Neurology | Pain | Pain Management